“Advances in the Pharmacotherapy of Heart Failure: Type 2 Sodium-Glucose Cotransporter Inhibitors (SGLT2) As a Therapeutic Option”. Research, Society and Development 12, no. 3 (March 1, 2023): e12412340502. Accessed June 28, 2025. https://ojs34.rsdjournal.org/index.php/rsd/article/view/40502.